IOL CHEMICALS & PHARM. | SUVEN PHARMACEUTICALS | IOL CHEMICALS & PHARM./ SUVEN PHARMACEUTICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 43.7 | 31.4% | View Chart |
P/BV | x | 1.6 | 9.3 | 16.7% | View Chart |
Dividend Yield | % | 1.0 | 0.9 | 105.8% |
IOL CHEMICALS & PHARM. SUVEN PHARMACEUTICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SUVEN PHARMACEUTICALS Mar-23 |
IOL CHEMICALS & PHARM./ SUVEN PHARMACEUTICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 629 | 85.3% | |
Low | Rs | 272 | 388 | 70.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 52.7 | 717.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 16.2 | 146.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 18.0 | 175.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 6.00 | 66.7% | |
Avg Dividend yield | % | 1.0 | 1.2 | 83.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 68.2 | 376.8% | |
Shares outstanding (eoy) | m | 58.71 | 254.57 | 23.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 9.7 | 11.1% | |
Avg P/E ratio | x | 17.1 | 31.5 | 54.2% | |
P/CF ratio (eoy) | x | 12.8 | 28.2 | 45.5% | |
Price / Book Value ratio | x | 1.6 | 7.5 | 21.1% | |
Dividend payout | % | 16.9 | 37.1 | 45.4% | |
Avg Mkt Cap | Rs m | 23,743 | 129,395 | 18.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,105 | 152.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 13,403 | 165.4% | |
Other income | Rs m | 256 | 464 | 55.2% | |
Total revenues | Rs m | 22,427 | 13,867 | 161.7% | |
Gross profit | Rs m | 2,257 | 5,739 | 39.3% | |
Depreciation | Rs m | 462 | 477 | 96.7% | |
Interest | Rs m | 165 | 128 | 128.6% | |
Profit before tax | Rs m | 1,887 | 5,597 | 33.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1,484 | 33.4% | |
Profit after tax | Rs m | 1,391 | 4,113 | 33.8% | |
Gross profit margin | % | 10.2 | 42.8 | 23.8% | |
Effective tax rate | % | 26.2 | 26.5 | 99.0% | |
Net profit margin | % | 6.3 | 30.7 | 20.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,554 | 83.7% | |
Current liabilities | Rs m | 5,025 | 3,031 | 165.8% | |
Net working cap to sales | % | 20.9 | 63.6 | 32.9% | |
Current ratio | x | 1.9 | 3.8 | 50.5% | |
Inventory Days | Days | 43 | 148 | 29.1% | |
Debtors Days | Days | 8 | 302 | 2.8% | |
Net fixed assets | Rs m | 11,017 | 9,547 | 115.4% | |
Share capital | Rs m | 587 | 255 | 230.6% | |
"Free" reserves | Rs m | 14,490 | 17,097 | 84.8% | |
Net worth | Rs m | 15,077 | 17,352 | 86.9% | |
Long term debt | Rs m | 0 | 46 | 0.0% | |
Total assets | Rs m | 20,684 | 21,101 | 98.0% | |
Interest coverage | x | 12.5 | 44.7 | 27.9% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 168.7% | |
Return on assets | % | 7.5 | 20.1 | 37.4% | |
Return on equity | % | 9.2 | 23.7 | 38.9% | |
Return on capital | % | 13.6 | 32.9 | 41.3% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 14,672 | 40.4% | |
Fx outflow | Rs m | 6,052 | 1,848 | 327.5% | |
Net fx | Rs m | -122 | 12,824 | -0.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 4,509 | 27.1% | |
From Investments | Rs m | -1,200 | -1,948 | 61.6% | |
From Financial Activity | Rs m | -41 | -2,358 | 1.7% | |
Net Cashflow | Rs m | -18 | 202 | -9.1% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 50.1 | - | |
Indian inst/Mut Fund | % | 1.7 | 26.8 | 6.3% | |
FIIs | % | 1.4 | 9.5 | 14.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.9 | 103.8% | |
Shareholders | 130,003 | 68,932 | 188.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SUVEN PHARMACEUTICALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.40% | -1.10% | 1.03% |
1-Month | 6.23% | -0.87% | 1.10% |
1-Year | 1.15% | 35.19% | 53.75% |
3-Year CAGR | -12.75% | 5.22% | 14.67% |
5-Year CAGR | 16.32% | 30.54% | 19.26% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SUVEN PHARMACEUTICALS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 50.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SUVEN PHARMACEUTICALS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SUVEN PHARMACEUTICALS paid Rs 6.0, and its dividend payout ratio stood at 37.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SUVEN PHARMACEUTICALS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.